(Q35679781)

9 August 2017

1 reference

title

Targeting the checkpoint kinases: chemosensitization versus chemoprotection (English)

1 reference

9 August 2017

Bin-Bing S Zhou

1

1 reference

PubMed ID

14993903

9 August 2017

Jiri Bartek

series ordinal

2

1 reference

PubMed ID

14993903

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

9 August 2017

Nature Reviews Cancer

1 reference

9 August 2017

4

1 reference

9 August 2017

216-225

1 reference

9 August 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc1296

9 August 2017

0 references

cites work

DNA and its associated processes as targets for cancer therapy

1 reference

Different drugs arrest cells at a number of distinct stages in G2.

31 March 2020

1 reference

Radiosensitivity in ataxia-telangiectasia: a new explanation

31 March 2020

1 reference

The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae

31 March 2020

1 reference

Checkpoints: controls that ensure the order of cell cycle events

31 March 2020

1 reference

The DNA damage response: putting checkpoints in perspective

31 March 2020

1 reference

DNA double-strand breaks: signaling, repair and the cancer connection

31 March 2020

1 reference

Cell cycle control and cancer

31 March 2020

1 reference

31 March 2020

1 reference

Cell cycle checkpoint signaling through the ATM and ATR kinases

31 March 2020

1 reference

Cell-cycle-dependent and ATM-independent expression of human Chk1 kinase

31 March 2020

1 reference

Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25

31 March 2020

1 reference

ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1

31 March 2020

1 reference

Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints

31 March 2020

1 reference

Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A.

31 March 2020

1 reference

Ataxia-telangiectasia-mutated (ATM) and NBS1-dependent phosphorylation of Chk1 on Ser-317 in response to ionizing radiation

31 March 2020

1 reference

Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents

31 March 2020

1 reference

Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts

31 March 2020

1 reference

Human claspin is required for replication checkpoint control

31 March 2020

1 reference

Rapid destruction of human Cdc25A in response to DNA damage

31 March 2020

1 reference

Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability

31 March 2020

1 reference

Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216

31 March 2020

1 reference

Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site

31 March 2020

1 reference

Maintenance of G2 arrest in the Xenopus oocyte: a role for 14-3-3-mediated inhibition of Cdc25 nuclear import

31 March 2020

1 reference

Chk1-deficient tumour cells are viable but exhibit multiple checkpoint and survival defects

31 March 2020

1 reference

The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01

31 March 2020

1 reference

Structural basis for Chk1 inhibition by UCN-01

31 March 2020

1 reference

Interference with PDK1-Akt survival signaling pathway by UCN-01 (7-hydroxystaurosporine).

31 March 2020

1 reference

Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice

31 March 2020

1 reference

ATR inhibition selectively sensitizes G1 checkpoint-deficient cells to lethal premature chromatin condensation

31 March 2020

1 reference

Activation of mammalian Chk1 during DNA replication arrest: a role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing

31 March 2020

1 reference

The Drosophila grapes gene is related to checkpoint gene chk1/rad27 and is required for late syncytial division fidelity

31 March 2020

1 reference

Inhibition of Chk1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells

31 March 2020

1 reference

Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C

31 March 2020

1 reference

UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.

31 March 2020

1 reference

Splitting the ATM: distinct repair and checkpoint defects in ataxia–telangiectasia

31 March 2020

1 reference

Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation

31 March 2020

1 reference

A derivative of an ataxia-telangiectasia (A-T) cell line with normal radiosensitivity but A-T-like inhibition of DNA synthesis

31 March 2020

1 reference

Separation of phenotypes in mutant alleles of the Schizosaccharomyces pombe cell-cycle checkpoint gene rad1+

31 March 2020

1 reference

Identification and characterization of new elements involved in checkpoint and feedback controls in fission yeast

31 March 2020

1 reference

Human Tousled like kinases are targeted by an ATM- and Chk1-dependent DNA damage checkpoint

31 March 2020

1 reference

Suppression of Tousled-like kinase activity after DNA damage or replication block requires ATM, NBS1 and Chk1

31 March 2020

1 reference

Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms

31 March 2020

1 reference

Linkage of ATM to cell cycle regulation by the Chk2 protein kinase

31 March 2020

1 reference

Mammalian Chk2 is a downstream effector of the ATM-dependent DNA damage checkpoint pathway

31 March 2020

1 reference

Determination of substrate motifs for human Chk1 and hCds1/Chk2 by the oriented peptide library approach.

31 March 2020

1 reference

A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase

31 March 2020

1 reference

31 March 2020

1 reference

The ATM-Chk2-Cdc25A checkpoint pathway guards against radioresistant DNA synthesis

31 March 2020

1 reference

The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways

31 March 2020

1 reference

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

31 March 2020

1 reference

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription

31 March 2020

1 reference

Chk2 is dispensable for p53-mediated G1 arrest but is required for a latent p53-mediated apoptotic response

31 March 2020

1 reference

Chk1 and Chk2 kinases in checkpoint control and cancer

31 March 2020

1 reference

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

31 March 2020

1 reference

Phosphorylation of Ser-20 mediates stabilization of human p53 in response to DNA damage

31 March 2020

1 reference

Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.

31 March 2020

1 reference

Mutation of mouse p53 Ser23 and the response to DNA damage

31 March 2020

1 reference

Questioning the role of checkpoint kinase 2 in the p53 DNA damage response

31 March 2020

1 reference

The Chk2 tumor suppressor is not required for p53 responses in human cancer cells

31 March 2020

1 reference

The mismatch repair system is required for S-phase checkpoint activation

31 March 2020

1 reference

Human MRE11 is inactivated in mismatch repair-deficient cancers

31 March 2020

1 reference

Ataxia telangiectasia-mutated protein can regulate p53 and neuronal death independent of Chk2 in response to DNA damage.

31 March 2020

1 reference

PML-dependent apoptosis after DNA damage is regulated by the checkpoint kinase hCds1/Chk2

31 March 2020

1 reference

Chk2 activates E2F-1 in response to DNA damage

31 March 2020

1 reference

A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy

31 March 2020

1 reference

The role of p53 in determining sensitivity to radiotherapy

31 March 2020

1 reference

Prevention of chemotherapy-induced alopecia in rats by CDK inhibitors

31 March 2020

1 reference

Involvement of the cohesin protein, Smc1, in Atm-dependent and independent responses to DNA damage

31 March 2020

1 reference

Different impact of p53 and p21 on the radiation response of mouse tissues

31 March 2020

1 reference

hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response

31 March 2020

1 reference

Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair

31 March 2020

1 reference

Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes

31 March 2020

1 reference

Interfaces between the detection, signaling, and repair of DNA damage

31 March 2020

1 reference

DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation

31 March 2020

1 reference

The Mre11 complex: at the crossroads of dna repair and checkpoint signalling

31 March 2020

1 reference

The cellular response to DNA double-strand breaks: defining the sensors and mediators

31 March 2020

1 reference

Fluorouracil: biochemistry and pharmacology

31 March 2020

1 reference

5-Fluorouracil: mechanisms of action and clinical strategies

31 March 2020

1 reference

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

31 March 2020

1 reference

Protection of normal tissues from the cytotoxic effects of chemotherapy and radiation by amifostine (WR-2721): preclinical aspects

31 March 2020

1 reference

Amifostine, cisplatin, and vinblastine in metastatic non-small-cell lung cancer: a report of high response rates and prolonged survival

31 March 2020

1 reference

Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy.

31 March 2020

1 reference

Selective killing of cancer cells by beta -lapachone: direct checkpoint activation as a strategy against cancer

31 March 2020

1 reference

31 March 2020

Identifiers

DOI

10.1038/NRC1296

1 reference

9 August 2017

1 reference

PubMed ID

14993903